Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
A massive second global wave of AIDS is coming — perhaps within the next 10 years

Three problems are driving the global fight against HIV into a new danger zone. First, new infections increasingly involve forms of the virus that are already resistant to the primary drugs used to treat and prevent HIV infection. Second, the world is fast approaching the limits of manufacturing capacity for anti-HIV first-line drugs, and the ceiling is far lower for second- and third-line treatments. And third, there aren’t sufficient financial resources applied to the AIDS problem now, and signals from major donors — especially the U.S. government — offer a grim future of diminished resources and greater demands on very poor countries to finance their own HIV fights without outside help.

Published
31 July 2017
From
Business Insider
Dutch study finds out whether gay men prefer daily or on-demand PrEP

In Europe, whether through national programmes or in trials, people are more often than not being given the choice of taking pre-exposure prophylaxis (PrEP) daily or intermittently

Published
28 July 2017
By
Gus Cairns
New Data Shows Dramatic Reduction in Chronic Diarrhea Episodes with Crofelemer (Mytesi) Treatment

Napo Pharmaceuticals, Inc., and Jaguar Animal Health, Inc. (Jaguar), announced today the results of a supplemental analysis of the long-term trial of crofelemer (Mytesi®) in patients with chronic HIV-related diarrhea. The analysis revealed a mean decrease of over 70 percent in diarrhea episodes versus baseline and over 50 percent of patients with complete resolution of their diarrhea.

Published
27 July 2017
From
Napo Pharmaceuticals press release
What can science learn from a child who has controlled HIV without drugs for more than 8 years?

An HIV-infected child in South Africa who is controlling the virus without antiretroviral (ARV) drugs has reinvigorated the push to find ways to allow people to control the virus for prolonged periods without treatment.

Published
27 July 2017
From
Science
Doravirine combination pill looks good for initial HIV treatment

A single-tablet regimen containing the next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) doravirine reduced HIV viral load as much as an efavirenz-based co-formulation, but it had a more

Published
27 July 2017
By
Liz Highleyman
Acute kidney injury ‘uncommon’ but unpredictable on tenofovir and ritonavir

Doctors need to monitor patients regularly for kidney function if they are taking tenofovir disoproxil, especially if combined with ritonavir, the 9th International AIDS Society Conference on HIV

Published
27 July 2017
By
Gus Cairns
Antibody helps keep man's HIV at bay for 10 months

An experimental therapy has held back one man's HIV infection for 10 months, doctors have reported. He was one of 18 people in a small trial testing injections of "broadly neutralising antibodies" - the natural weapons of the immune system.

Published
26 July 2017
From
BBC News
Drug interaction concerns may negatively affect HIV treatment adherence among transgender women

Participants in NIH-supported study apprehensive about combining HIV medications and hormones.

Published
25 July 2017
From
NIAID
Integrase inhibitors not causing higher rates of adverse birth outcomes, Botswana and French studies show

Dolutegravir-based antiretroviral therapy (ART) started in pregnancy is as safe as efavirenz-based ART, according to a study of birth outcomes at eight maternity wards throughout Botswana accounting for

Published
25 July 2017
By
Carole Leach-Lemens
New guidance says start HIV treatment within 7 days of diagnosis – but is everyone ready?

Everyone diagnosed with HIV should be offered the option to start treatment within seven days of diagnosis and everyone who feels ready should have the option to

Published
25 July 2017
By
Keith Alcorn

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.